The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression

INTRODUCTION: The inhaled corticosteroid (ICS) fluticasone furoate is in development, in combination with the long-acting beta(2)-agonist vilanterol for the once-daily treatment of asthma and chronic obstructive pulmonary disease and as a monotherapy treatment for asthma. Corticosteroids, including...

Descripción completa

Detalles Bibliográficos
Autor principal: Allen, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779313/
https://www.ncbi.nlm.nih.gov/pubmed/23719680
http://dx.doi.org/10.1007/s40262-013-0078-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779313/
https://www.ncbi.nlm.nih.gov/pubmed/23719680
http://dx.doi.org/10.1007/s40262-013-0078-1

Ejemplares similares